Reduced gut microbial diversity in familial hypercholesterolemia with no effect of omega-3 polyunsaturated fatty acids intervention

Reduced gut microbial diversity in familial hypercholesterolemia with no effect of omega-3 polyunsaturated fatty acids intervention – a pilot trial

Published:2022-08-01 Issue:5 Volume:82 Page:363-370
ISSN:0036-5513
Container-title:Scandinavian Journal of Clinical and Laboratory Investigation
language:en
Short-container-title:Scandinavian Journal of Clinical and Laboratory Investigation

Author:

Storm-Larsen Christopher¹²³^ORCID,Hande Liv Nesse⁴⁵,Kummen Martin¹²³⁶,Thunhaug Hilde⁴,Vestad Beate¹³,Hansen Simen Hyll¹²³,Hovland Anders⁴⁷,Trøseid Marius¹³⁸,Lappegård Knut Tore⁴⁷,Hov Johannes R.¹²³⁹^ORCID

Affiliation:

1. Institute of Clinical Medicine, University of Oslo, Oslo, Norway

2. Department of Transplantation Medicine, Division of Surgery, Inflammatory diseases and Transplantation, Norwegian PSC Research Center, Oslo University Hospital, Oslo, Norway

3. Division of Surgery, Inflammatory diseases and Transplantation, Research Institute of Internal Medicine, Oslo University Hospital, Oslo, Norway

4. Division of Internal Medicine, Nordland Hospital, Bodø, Norway

5. Faculty of Health Sciences, University of Tromsø, Tromsø, Norway

6. Department of Oncology, Oslo University Hospital, Oslo, Norway

7. Institute of Clinical Medicine, University of Tromsø, Tromsø, Norway

8. Section of Clinical Immunology and Infectious diseases, Division of Cancer Medicine, Surgery and Transplantation, Oslo University Hospital, Oslo, Norway

9. Department of Transplantation Medicine, Section of Gastroenterology, Oslo University Hospital, Oslo, Norway

Publisher

Informa UK Limited

Subject

Clinical Biochemistry,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/00365513.2022.2102540

Reference40 articles.

1. 2.5-fold increased risk of recurrent acute myocardial infarction with familial hypercholesterolemia

2. Familial hypercholesterolaemia

3. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk

4. Population-based metagenomics analysis reveals markers for gut microbiome composition and diversity

5. Richness of human gut microbiome correlates with metabolic markers

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Type 3 resistant starch from Canna edulis reduce lipid levels in patients with mild hyperlipidemia through altering gut microbiome: A double- blind randomized controlled trial;Pharmacological Research;2024-07

2. Advances in Gut Microbiota-Targeted Therapeutics for Metabolic Syndrome;Microorganisms;2024-04-24

3. Coriobacteriia Can Affect The Developing of Hepatocellular Carcinoma Through The Pyrimidine, Caffeine, Urea Cycle and Glutamate Metabolic Pathways;2024-03-11

4. Towards personalized genome-scale modeling of inborn errors of metabolism for systems medicine applications;Metabolism;2024-01

5. Variations in the Relative Abundance of Gut Bacteria Correlate with Lipid Profiles in Healthy Adults;Microorganisms;2023-10-28